Related Experiment Video
Updated: Jun 11, 2025

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.5K
Mastectomy Skin Flap Perfusion Assessment Prior to Breast Reconstruction: A Narrative Review
Alex Victor Orădan1,2,3, Alexandru Valentin Georgescu1,2, Alexandru Ilie-Ene4,5
1Department of Surgery-Plastic and Reconstructive Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Journal of Personalized Medicine
|September 28, 2024
Summary
Predicting skin flap viability after mastectomy is crucial for breast reconstruction. Indocyanine green angiography is currently preferred for perfusion assessment, though new technologies show promise.
Area of Science:
- Surgical Oncology
- Plastic and Reconstructive Surgery
- Medical Imaging
Background:
- Assessing skin flap viability post-mastectomy is critical for successful immediate breast reconstruction.
- Various methods exist for evaluating flap perfusion, necessitating a comparative review.
Purpose of the Study:
- To describe and compare current preferred perfusion assessment tools for skin flaps after mastectomy.
- To provide an overview of established and emerging techniques in flap viability monitoring.
Main Methods:
- A systematic literature search was conducted across four major databases (Web of Science, PubMed, Embase, Scopus).
- Included studies were reviews, meta-analyses, clinical trials, experimental studies, and case reports published in English within the last 10 years.
- The last search was performed on July 31, 2024.
Main Results:
- Fifty-eight studies were included in the review.
- A synthesis and comparison of relevant information from included studies were performed.
- Indocyanine green angiography (ICG-A) emerged as the most frequently utilized method.
Conclusions:
- Indocyanine green angiography (ICG-A) is the current gold standard for evaluating skin flap perfusion, particularly in high-risk patients.
- Emerging technologies demonstrate potential for future applications in flap viability assessment.
- Perfusion assessment tools should augment, not replace, clinical judgment in patient care.

